Symptom Improvement Following Treatment with the Inhaled Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine in Patients with Moderate to Severe COPD - A Detailed Analysis.
Int J Chron Obstruct Pulmon Dis
; 15: 2199-2206, 2020.
Article
in En
| MEDLINE
| ID: mdl-32982212
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyrimidinones
/
Phosphoric Diester Hydrolases
/
Pulmonary Disease, Chronic Obstructive
/
Isoquinolines
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Prognostic_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Int J Chron Obstruct Pulmon Dis
Year:
2020
Document type:
Article
Affiliation country:
Germany